🔗 Share this article Treasury Chief Reeves Aims for Specific Action on Living Costs in Upcoming Financial Plan Treasury head Rachel Reeves has revealed she is preparing "targeted steps to address household expense issues" in next month's Budget. During an interview with media outlets, she stated that curbing price rises is a collective task of both the administration and the central bank. The United Kingdom's inflation rate is projected to be the highest among the G7 industrialized countries this year and the following year. Possible Energy Bill Measures Sources suggest the administration could take action to bring down energy bills, for instance by cutting the present 5% rate of VAT charged on energy. A further approach is to reduce some of the regulatory levies presently added to household expenses. Budgetary Constraints and Analyst Predictions The administration will receive the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will clarify how much scope there is for such measures. The view from most experts is that Reeves will have to introduce tax increases or spending cuts in order to adhere to her voluntary borrowing rules. Previously on Thursday, calculations indicated there was a twenty-two billion pound shortfall for the Treasury chief to fill, which is at the more modest range of expectations. "It is a joint job between the central bank and the government to bear down further on some of the causes of price increases," Reeves told the BBC in the US capital, at the conferences of the IMF and World Bank. Tax Pledges and Global Concerns While a great deal of the attention has been on expected tax increases, the Treasury chief said the most recent data from the fiscal watchdog had not altered her vow to campaign commitments not to increase tax levels on earnings tax, sales tax or social security contributions. She blamed an "unpredictable world" with rising international and commercial tensions for the Budget tax moves, probably to be focused on those "most able to pay." International Economic Disputes Referring to apprehensions about the United Kingdom's economic relations with the Asian nation she said: "The UK's national security always are paramount." Last week's statement by Chinese authorities to strengthen export controls on critical minerals and other materials that are essential for high-technology manufacturing led US President the US President to propose an additional 100% import tax on goods from the Asian country, increasing the prospect of an all-out trade war between the two global powers. The American finance chief labeled China's action "economic coercion" and "a global supply chain control attempt." Inquired about accepting the American proposal to join its conflict with China, the Chancellor said she was "very concerned" by China's actions and encouraged the Chinese government "not to put up barriers and limit trade." She said the move was "harmful for the global economy and creates further headwinds." "In my view there are areas where we need to confront Chinese policies, but there are also significant chances to sell into China's economy, including financial services and other sectors of the economy. We've got to maintain that balance right." The Treasury chief also stated she was cooperating with G7 counterparts "on our own critical minerals plan, so that we are more independent." Health Service Drug Pricing and Funding The Chancellor also acknowledged that the cost the NHS pays for drugs could rise as a consequence of ongoing negotiations with the US government and its drugs companies, in return for reduced taxes and investment. A number of the biggest global drug companies have said recently that they are either halting or canceling projects in the UK, with several attributing the insufficient payments they are obtaining. Recently, the Science Minister said the cost the NHS pays for medicines would have to rise to halt companies and pharmaceutical investment departing from the United Kingdom. Reeves told the BBC: "It has been observed because of the pricing regime, that drug testing, innovative medicines have not been offered in the United Kingdom in the way that they are in other European countries." "The objective is to guarantee that patients receiving treatment from the NHS are able to receive the finest essential medicines in the world. And so we are looking at this situation, and... seeking to obtain more investment into Britain."